Bernstein raised the price target for the Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) stock to “a Mkt perform”. The rating was released on March 07, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Jefferies that downgraded the stock from a Buy to an Underperform with a price target of $11.70 for FMS stock.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) dipped -1.33% to close Thursday’s market session at $19.32, lower as compared to yesterday’s close. The stock price fluctuated between $19.25 and $19.525 throughout the trading session with the volume trading being 3496933 shares, which represented a significant variation when compared to the three months average volume of 865.91K shares. The firm’s stock price fluctuated 2.06% within the last five trades and -3.59% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 14.86% in the last 6 months and 19.63% was added to its value over the previous 3 months. FMS stock is trading at a margin of -1.91%, 2.34% and 4.33% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
As of the close of trading, FMS deals in the Healthcare domain. The stock is trading -44.24 percent below its 52-week high and 51.11 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -31.8. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Fresenius Medical Care AG & Co. KGaA’s Profitability and Valuation Ratios Tell Us About the Stock?
The stock’s market cap achieved a total value of $11.41 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is 16.10. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 7.58. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 0.59 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 0.81, which equates the market value of a stock with its book value.